A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial
Table 5
Serum antibody response induced by a second 103 PFU dose of rDEN1Δ30 given at 4 or 6 months after first dose.